Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CACA 2025 | Emerging scientific pathways shaping cancer medicine in China

Yongsheng Li • 6 Nov 2025
CACA 2025
General

Yongsheng Li, MD, Chongqing University Cancer Hospital, Chongqing, China, comments on the current state of oncology research and clinical translation in China. National policies have resulted in advances in areas such as tumor immunometabolism and metabolomics, which potentially have clinical implications. This interview took place at the 2025 Chinese Anti-Cancer Association (CACA) Science & Technology Award Talks in Kunming, China.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Related Videos

Management of cancer-related cognitive impairment in patients
2:44
Management of cancer-related cognitive impairment in patients
Filippos Koinis • 1 Jun 2026
What are the key determinants of cancer-related cognitive impairment?
3:25
What are the key determinants of cancer-related cognitive impairment?
Filippos Koinis • 1 Jun 2026
Gender representation in Phase III solid tumor trials at ASCO 2015-2025
1:24
Gender representation in Phase III solid tumor trials at ASCO 2015-2025
Sarbajit Mukherjee • 1 Jun 2026
Quality gaps in online patient information about AI in cancer care
1:24
Quality gaps in online patient information about AI in cancer care
Eleonora Teplinsky • 31 May 2026
The content of VJOncology is intended for healthcare professionals